Arcosa, Inc. Common Stock (ACA) is a publicly traded Industrials sector company. As of May 21, 2026, ACA trades at $120.24 with a market cap of $6.00B and a P/E ratio of 26.33. ACA moved +2.48% today. Year to date, ACA is +10.45%; over the trailing twelve months it is +37.65%. Its 52-week range spans $68.11 to $135.58. Analyst consensus is strong buy with an average price target of $131.25. Rallies surfaces ACA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Arcosa rises as raised 2026 guidance and new $146 target lift sentiment: Arcosa shares are higher as investors digest a Q1 2026 beat and a raised full-year outlook for continuing operations announced April 30, 2026. The move is being reinforced by a fresh analyst price-target increase to $146 issued May 5, 2026 as the stock trades near record highs.
| Metric | Value |
|---|---|
| Price | $120.24 |
| Market Cap | $6.00B |
| P/E Ratio | 26.33 |
| EPS | $4.54 |
| Dividend Yield | 0.05% |
| 52-Week High | $135.58 |
| 52-Week Low | $68.11 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $2.82B |
| Net Income | $222.60M |
| Gross Margin | 22.77% |
4 analysts cover ACA: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $131.25.